5-Years Analysis of Effectivity and Toxicity of Ultra-Hypofractionated Proton Radiotherapy in the Treatment of Low- and Intermediate-Risk Prostate Cancer-A Retrospective Analysis.

Jiri Kubeš,Silvia Sláviková,Pavel Vítek,Alexandra Haas,Barbora Ondrová,Kateřina Dedečková,Michal Andrlík, Martin Domanský,Kateřina Jiránková, Veronika Schlencová, Anh Harazimová, Barbora Turková,Tomáš Doležal,Sarah Falah Abass Al-Hamami,Vladimír Vondráček

Cancers（2023）

引用 0|浏览9

暂无评分

摘要

Ultra-hypofractionated proton beam radiotherapy is an effective treatment for low- and favorable intermediate-risk prostate cancer, with long-term bDFS rates comparable to other techniques. It is promising for unfavorable intermediate-risk prostate cancer and has acceptable long-term GI and favorable GU toxicity.

查看译文

关键词

proton radiotherapy,prostate cancer—a,ultra-hypofractionated,intermediate-risk

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要